Skip to main content
. Author manuscript; available in PMC: 2017 Dec 15.
Published in final edited form as: J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):572–580. doi: 10.1097/QAI.0000000000001145

Table 3. Mean difference in log10 maternal plasma HIV RNA by adherence category.

Complete case Imputed Unadjusted
Unadjusted Adjusted* Unadjusted Adjusted*
Mean diff** (95% CI) Mean diff** (95% CI) Mean diff** (95% CI) Mean diff** (95% CI)
Maternal and Infant Arm
81-98% adherent vs 0-80% -0.82 (-1.09, -0.55) -0.93 (-1.19, -0.68) -0.45 (-0.76, -0.15) -0.52 (-0.82, -0.22)
>98% adherent vs 0-80% -0.69 (-0.93, -0.45) -0.75 (-0.98, -0.52) -0.37 (-0.65, -0.08) -0.42 (-0.70, -0.15)
Maternal arm only
81-98% adherent vs 0-80% -0.07 (-0.45, 0.30) -0.08 (-0.45, 0.29) 0.01 (-0.31, 0.33) 0.01 (-0.31, 0.33)
>98% adherent vs 0-80% 0.09 (-0.25, 0.44) 0.10 (-0.24, 0.44) 0.11 (-0.19, 0.41) 0.12 (-0.18, 0.41)
*

Adjusted for: baseline maternal age, baseline maternal CD4+ count, baseline log10 plasma viral load, and nutrition randomization

**

Mean difference in log10 maternal plasma viral load by adherence category (referent: 0-80% adherence), based on mixed linear regression with log10 plasma viral load as outcome

In complete case analyses, a total of 47, 89, and 117 pill count adherence measures were in the 0-80%, 81-98%, and >98% adherence categories, respectively